- Home
- CURI vs LUCD Comparison
CURI vs LUCD Comparison
Compare CURI & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CURI | LUCD |
|---|---|---|
| Founded | N/A | 2018 |
| Country | United States | United States |
| Employees | 42 | N/A |
| Industry | Movies/Entertainment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.9M | 190.8M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | CURI | LUCD |
|---|---|---|
| Price | $2.46 | $1.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $5.83 | $4.13 |
| AVG Volume (30 Days) | 326.2K | ★ 839.4K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | ★ 10.36% | N/A |
| EPS Growth | N/A | ★ 16.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,346,000.00 |
| Revenue This Year | $14.91 | $115.58 |
| Revenue Next Year | $12.91 | $130.54 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 79.00 |
| 52 Week Low | $2.81 | $0.95 |
| 52 Week High | $7.15 | $1.70 |
Technical Indicators
Market Signals| Indicator | CURI | LUCD |
|---|---|---|
| Relative Strength Index (RSI) | 29.55 | 34.52 |
| Support Level | N/A | N/A |
| Resistance Level | $3.56 | $1.12 |
| Average True Range (ATR) | 0.17 | 0.05 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 15.64 | 27.74 |
Price Performance
Historical ComparisonAbout CURI CuriosityStream Inc.
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. The firm's products and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, and Others. The majority of the revenue comes from the direct business and Content licensing. Geographically, the company generates the majority of its revenue from the United States.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.